Embargoed news from Annals of Internal Medicine

November 05, 2012

1. Follow Up Surveillance with Less Invasive, Less Costly Tests Could Make Colonoscopy a One-time Test for Some Patients

Following a negative colonoscopy result at initial screening, regular follow-up with less-invasive screening tools may provide the same life-saving benefit with fewer risks for complication and at a lower cost than rescreening with colonoscopy every 10 years. Researchers used a microsimulation model to assess the effectiveness and costs of colonoscopy versus other rescreening strategies after an initial negative colonoscopy result. The model compared several rescreening interventions for persons aged 50 years who had no adenomas or cancer detected on an initial screening colonoscopy. Interventions included no further screening or rescreening with colonoscopy every 10 years, annual screening with fecal occult blood testing or fecal immunochemical testing, or computed tomographic colonography (CTC) every five years. The data showed that compared with no further screening, all rescreening strategies provided approximately the same benefit in life-years as colonoscopy every 10 years, but with fewer complications and at a lower cost. While life-years saved were similar in all intervention groups, the authors of an accompanying editorial caution that screening reduces colorectal cancer mortality because earlier-stage cancer is less likely to result in death. But highly-sensitive endoscopic screening methods like colonoscopy may be more effective in reducing cancer incidence than FOBT. The editorialists argue that if the study authors had measured for quality-adjusted life-years, they might have reached a different conclusion. They suggest that most people would likely pay more to never have colorectal cancer at all than to suffer with cancer and survive.

Note: For an embargoed PDF, contact Angela Collom or Megan Hanks. To interview the study author, Dr. Amy Knudsen, please contact Sue McGreevey at smcgreevey@partners.org or 617-724-2764. To interview lead editorialist, Dr. David Weinberg, please contact Diana Quattrone at 215-728-7784 or Diana.quattrone@fccc.edu.




2. Initial Treatment with Sulfonylureas Increases Cardiovascular Events and Death in Diabetes Patients

Patients who initiated treatment for diabetes with sulfonylureas had a higher rate of cardiovascular events and death compared to patients initiating treatment with metformin. Researchers reviewed data on 253,690 veterans initiating treatment for diabetes to compare the effects of sulfonylureas (n= 98,665 patients) and metformin (n = 155,025 patients) on cardiovascular disease (CVD) outcomes or death. They found that sulfonylurea use was associated with a 21 percent increased risk of acute myocardial infarction, stroke, or death. The researchers could not conclude whether sulfonylureas themselves are harmful, or if metformin is protective. They also could not determine if differences in patient characteristics could account for rates of cardiovascular events and death among patients taking sulfonylureas. According to the researchers, these observations support the use of metformin for first-line diabetes therapy. The author of an accompanying editorial has studied the cardiovascular outcomes associated with diabetes therapies. While observational data is useful and credible, it does not provide a definitive answer as to why sulfonylureas increase adverse cardiovascular outcomes. The author suggests that public health authorities sponsor a randomized controlled trial to provide high-quality evidence on the issue.

Note: For an embargoed PDF, contact Angela Collom or Megan Hanks. To speak with lead author, Dr. Christianne Roumie, please contact Craig Boerner, at boerner@vanderbilt.edu or 615-322-4747. To speak with the editorialist, Dr. Steven Nissen, please contact Tora Vinci at vinciv@ccf.org or 216-339-4277.




3. Consistent Aerobic Exercise Best Way for Patients to Self-manage Osteoarthritis Knee Pain

Low-strength evidence suggests that aerobic and aquatic exercise can reduce pain and improve function and disability for community-dwelling adults with osteoarthritis-associated knee pain. Researchers conducted a literature review of 193 published randomized, controlled trials on physical therapy interventions for community-dwelling adults with knee osteoarthritis. Interventions were analyzed for their effect on pain reduction, physical function, and disability. Physical therapy interventions reviewed included education programs, proprioception exercise, aerobic exercise, aquatic exercise, strength training, tai chi, massage, orthotics, taping, electrical stimulation, pulsed electromagnetic fields, ultrasonography, and diathermy. Few physical therapy interventions were effective at reducing knee pain or improving function and disability. The researchers found low-strength evidence that aerobic and aquatic exercise improved disability and that aerobic exercise, strength training, and ultrasonography reduced pain and improved function. Patients with high adherence to their exercise program had better outcomes, leading the researchers to conclude that therapeutic exercise programs should focus on achieving higher adherence rather than increasing the amount or intensity of exercise.

Note: For an embargoed PDF, contact Angela Collom or Megan Hanks. For interviews, please contact lead author, Dr. Tatyana Shamliyan, directly at shaml005@umn.edu.
-end-


American College of Physicians

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.